title: Replacement of murine leukemia virus readthrough mechanism by human immunodeficiency virus frameshift allows synthesis of viral proteins and virus replication.
abstract: Retroviruses use unusual recoding strategies to synthesize the Gag-Pol polyprotein precursor of viral enzymes. In human immunodeficiency virus, ribosomes translating full-length viral RNA can shift back by 1 nucleotide at a specific site defined by the presence of both a slippery sequence and a downstream stimulatory element made of an extensive secondary structure. This so-called frameshift mechanism could become a target for the development of novel antiviral strategies. A different recoding strategy is used by other retroviruses, such as murine leukemia viruses, to synthesize the Gag-Pol precursor; in this case, a stop codon is suppressed in a readthrough process, again due to the presence of a specific structure adopted by the mRNA. Development of antiframeshift agents will greatly benefit from the availability of a simple animal and virus model. For this purpose, the murine leukemia virus readthrough region was rendered inactive by mutagenesis and the frameshift region of human immunodeficiency virus was inserted to generate a chimeric provirus. This substitution of readthrough by frameshift allows the synthesis of viral proteins, and the chimeric provirus sequence was found to generate infectious viruses. This system could be a most interesting alternative to study ribosomal frameshift in the context of a virus amenable to the use of a simple animal model.
authors.affiliation: Département de Biochimie, Université de Montréal, Montréal, Québec, Canada H3C 3J7.
authors.forename: Marie-Noëlle
authors.initials: MN
authors.lastname: Brunelle
authors.forename: Léa
authors.initials: L
authors.lastname: Brakier-Gingras
authors.forename: Guy
authors.initials: G
authors.lastname: Lemay
mesh_terms: D016475:3T3 Cells; D000818:Animals; D001483:Base Sequence; D018965:Frameshifting, Ribosomal / Q000235:genetics*; D015685:Fusion Proteins, gag-pol; D015967:Gene Expression Regulation, Viral; D015750:Genes, gag / Q000235:genetics; D015751:Genes, pol / Q000235:genetics; D015497:HIV-1 / Q000235:genetics* / Q000378:metabolism / Q000502:physiology; D006801:Humans; D051379:Mice; D008969:Molecular Sequence Data; D008979:Moloney murine leukemia virus / Q000235:genetics* / Q000378:metabolism / Q000502:physiology; D016297:Mutagenesis, Site-Directed; D014176:Protein Biosynthesis; D012367:RNA, Viral / Q000096:biosynthesis; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000378:metabolism; D014764:Viral Proteins / Q000378:metabolism*; D014779:Virus Replication
chemical_list: D015685:Fusion Proteins, gag-pol; D012367:RNA, Viral; D011993:Recombinant Fusion Proteins; D014764:Viral Proteins